Literature DB >> 14752668

The relationship between HRCT and pulmonary function in Behcet's disease.

H Uysal1, S Balevi, N Okudan, H Gökbel.   

Abstract

The purpose of this study was to compare the pulmonary functions in female Behcet's patients with or without pathological pulmonary lesions using high resolution computerized tomography (HRCT). Twenty-nine female patients aged 19-54 yrs and 20 healthy females aged 19-50 yrs (control group) were accepted into the study. HRCT images were taken and according to HRCT patients were divided into HRCT (+) and HRCT (-) groups (18 patients in each). Pulmonary function tests (PFT) through a spirometer were performed and FVC, FEV(1), FEF(25-75%), PEF, VC, RV, FRC, DLCO and DLCO/VA were determined. No statistically significant difference was observed when the PFT values were compared between HRCT (+) and HRCT (-) patients for the obtained results and the percentage of the expected values. When the PFT values were compared for both HRCT (+) and HRCT (-) patients with the control group separately there was no statistical difference between the best values. A statistically low DLCO/VA value was observed between the percentage of the expected values. It is concluded that though there is a pulmonary restriction in Behcet's disease, this restriction has no relation to pulmonary functions. It would be useful to perform pulmonary function tests in the patients with Behcet's disease both with or without any pathological findings in HRCT for obtaining information about pulmonary functions. We suggest that even when the results of the pulmonary function tests are normal, considering some pathological changes in HRCT, HRCT investigations may be useful for following up the disease.

Entities:  

Mesh:

Year:  2004        PMID: 14752668     DOI: 10.1007/s00408-003-1040-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  18 in total

1.  Thoracic involvement in Behçet's disease and its correlation with multiple parameters.

Authors:  H Gunen; C Evereklioglu; F Kosar; H Er; O Kizkin
Journal:  Lung       Date:  2000       Impact factor: 2.584

2.  Obstructive lung disease in Behcet's syndrome.

Authors:  A V Ahonen; B S Stenius-Aarniala; B C Viljanen; P E Halttunen; P Oksa; K V Mattson
Journal:  Scand J Respir Dis       Date:  1978-02

Review 3.  Behçet's Disease.

Authors:  V G Kaklamani; G Vaiopoulos; P G Kaklamanis
Journal:  Semin Arthritis Rheum       Date:  1998-02       Impact factor: 5.532

4.  Behçet's disease in Saudi Arabia.

Authors:  A N al-Dalaan; S R al Balaa; K el Ramahi; Z al-Kawi; S Bohlega; S Bahabri; M A al Janadi
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

5.  Pulmonary involvement in Behcet disease.

Authors:  P Grenier; O Bletry; F Cornud; P Godeau; H Nahum
Journal:  AJR Am J Roentgenol       Date:  1981-09       Impact factor: 3.959

6.  Pulmonary disease in Behçet's syndrome.

Authors:  J Efthimiou; C Johnston; S G Spiro; M Turner-Warwick
Journal:  Q J Med       Date:  1986-03

7.  Thoracic manifestations of Behçet syndrome: radiographic and CT findings in nine patients.

Authors:  J M Ahn; J G Im; J W Ryoo; S J Kim; Y S Do; Y W Choi; Y W Oh; K M Yeon; M C Han
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

8.  Pulmonary CT findings in Behçet disease.

Authors:  H T Winer-Muram; M L Gavant
Journal:  J Comput Assist Tomogr       Date:  1989 Mar-Apr       Impact factor: 1.826

9.  [Behcet's disease with pulmonary vessel involvement].

Authors:  E Wiatr; B Chmielewska; E Jotowicz; L Pawlicka; P Remiszewski; E Rowińska-Zakrzewska
Journal:  Pneumonol Alergol Pol       Date:  1997

Review 10.  Pulmonary vasculitis.

Authors:  E J Sullivan; G S Hoffman
Journal:  Clin Chest Med       Date:  1998-12       Impact factor: 2.878

View more
  1 in total

1.  Evaluation of pulmonary function and bicycle ergometry tests in patients with Behçet's disease.

Authors:  Figen Gökoğlu; Z Rezan Yorgancioğlu; Nilgün Ustün; Figen Ayhan Ardiç
Journal:  Clin Rheumatol       Date:  2007-01-10       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.